Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.990
-0.090 (-1.77%)
At close: Feb 21, 2025, 4:00 PM
5.23
+0.24 (4.81%)
After-hours: Feb 21, 2025, 7:36 PM EST
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $370.27 million as of February 21, 2025. Its market cap has decreased by -56.51% in one year.
Market Cap
370.27M
Enterprise Value
157.21M
1-Year Change
-56.51%
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $370.27M, a decrease of -79.37%. That is a compound annual growth rate of -30.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 370.27M | -13.90% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.33B |
| UnitedHealth Group | 464.62B |
| Johnson & Johnson | 384.23B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.65B |
| Abbott Laboratories | 230.47B |
| AstraZeneca | 228.16B |
| Merck & Co. | 219.69B |